Evidence map›Paper›PMID 33978813›Full record

ArticleActa neuropathologica2021

Multiple system atrophy-associated oligodendroglial protein p25α stimulates formation of novel α-synuclein strain with enhanced neurodegenerative potential.

Nelson Ferreira, Hjalte Gram, Zachary A Sorrentino, Emil Gregersen, Sissel Ida Schmidt, Lasse Reimer, Cristine Betzer, Clara Perez-Gozalbo, Marjo Beltoja, Madhu Nagaraj and 16 more

Open access · hybridAbstract read
In one paragraph

Article in Acta neuropathologica, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 64 papers.

0numbers the graph read from it
0cells of the map it votes in
64citing papers in PubMed
7.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

64 citing papers in PubMed, 82 citations in OpenAlex.

  1. Multiple system atrophy: cure and care.Journal of neural transmission (Vienna, Austria : 1996) · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

4 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors at 6 institutions in 4 countries.

Nelson FerreiraDANDRITE, Danish Research Institute of Translational Neuroscience & Department of Biomedicine, Aarhus University, 8000, Aarhus C, Denmark. nelson@biomed.au.dk.ORCID http://orcid.org/0000-0002-0305-9097
Hjalte GramDANDRITE, Danish Research Institute of Translational Neuroscience & Department of Biomedicine, Aarhus University, 8000, Aarhus C, Denmark.
Zachary A SorrentinoDepartment of Neuroscience, Center for Translational Research in Neurodegenerative Diseases and McKnight Brain Institute, University of Florida, Gainesville, USA.
Emil GregersenDANDRITE, Danish Research Institute of Translational Neuroscience & Department of Biomedicine, Aarhus University, 8000, Aarhus C, Denmark.
Sissel Ida SchmidtDepartment of Neurobiology Research, Institute of Molecular Medicine, University of Southern Denmark, J.B. Winsloews Vej 21, st, 5000, Odense C, Denmark.
Lasse ReimerDANDRITE, Danish Research Institute of Translational Neuroscience & Department of Biomedicine, Aarhus University, 8000, Aarhus C, Denmark.
Cristine BetzerDANDRITE, Danish Research Institute of Translational Neuroscience & Department of Biomedicine, Aarhus University, 8000, Aarhus C, Denmark.
Clara Perez-GozalboDANDRITE, Danish Research Institute of Translational Neuroscience & Department of Biomedicine, Aarhus University, 8000, Aarhus C, Denmark.
Marjo BeltojaDANDRITE, Danish Research Institute of Translational Neuroscience & Department of Biomedicine, Aarhus University, 8000, Aarhus C, Denmark.
Madhu NagarajInterdisciplinary Nanoscience Center (iNANO), Aarhus University, 8000, Aarhus C, Denmark.
Jie WangInterdisciplinary Nanoscience Center (iNANO), Aarhus University, 8000, Aarhus C, Denmark.
Jan S NowakInterdisciplinary Nanoscience Center (iNANO), Aarhus University, 8000, Aarhus C, Denmark.
Mingdong DongInterdisciplinary Nanoscience Center (iNANO), Aarhus University, 8000, Aarhus C, Denmark.
Katarina WillénDepartment of Cell Biology, H. Lundbeck A/S, Valby, Denmark.
Ersoy CholakDepartment of Cell Biology, H. Lundbeck A/S, Valby, Denmark.
Kaare Bjerregaard-AndersenDepartment of Cell Biology, H. Lundbeck A/S, Valby, Denmark.
Nicolas MendezMitchell Center for Alzheimer's Disease and Related Brain Disorders, Department of Neurology, University of Texas McGovern Medical School At Houston, Houston, TX, USA.
Prakruti RabadiaMitchell Center for Alzheimer's Disease and Related Brain Disorders, Department of Neurology, University of Texas McGovern Medical School At Houston, Houston, TX, USA.
Mohammad ShahnawazMitchell Center for Alzheimer's Disease and Related Brain Disorders, Department of Neurology, University of Texas McGovern Medical School At Houston, Houston, TX, USA.
Claudio SotoMitchell Center for Alzheimer's Disease and Related Brain Disorders, Department of Neurology, University of Texas McGovern Medical School At Houston, Houston, TX, USA.
Daniel E OtzenInterdisciplinary Nanoscience Center (iNANO), Aarhus University, 8000, Aarhus C, Denmark.
Ümit AkbeyInterdisciplinary Nanoscience Center (iNANO), Aarhus University, 8000, Aarhus C, Denmark.
Morten MeyerDepartment of Neurobiology Research, Institute of Molecular Medicine, University of Southern Denmark, J.B. Winsloews Vej 21, st, 5000, Odense C, Denmark.
Benoit I GiassonDepartment of Neuroscience, Center for Translational Research in Neurodegenerative Diseases and McKnight Brain Institute, University of Florida, Gainesville, USA.
Marina Romero-RamosDANDRITE, Danish Research Institute of Translational Neuroscience & Department of Biomedicine, Aarhus University, 8000, Aarhus C, Denmark.
Poul Henning JensenDANDRITE, Danish Research Institute of Translational Neuroscience & Department of Biomedicine, Aarhus University, 8000, Aarhus C, Denmark. phj@biomed.au.dk.ORCID http://orcid.org/0000-0002-4439-9020
Aarhus University · DKLundbeck (Denmark) · DKUniversity of Florida · USUniversity of Southern Denmark · DKForschungszentrum Jülich · DEJiangsu University · CN

Funding

Prion and non-prion induction mechanisms of alpha-synuclein pathologyR01NS100876 · NINDS · UNIVERSITY OF FLORIDA · PI BORCHELT, DAVID R, GIASSON, BENOIT I · 2018 to 2022
$1.9M
Towards Understanding the Initiating Role of Truncated Alpha-Synuclein in NeurodegenerationF30AG063446 · NIA · UNIVERSITY OF FLORIDA · PI SORRENTINO, ZACHARY A · 2019 to 2022
$122k
NIA NIH HHS F30 AG063446NINDS NIH HHS R01 NS100876
6 · The paper itself

Abstract

Pathology consisting of intracellular aggregates of alpha-Synuclein (α-Syn) spread through the nervous system in a variety of neurodegenerative disorders including Parkinson's disease, dementia with Lewy bodies, and multiple system atrophy. The discovery of structurally distinct α-Syn polymorphs, so-called strains, supports a hypothesis where strain-specific structures are templated into aggregates formed by native α-Syn. These distinct strains are hypothesised to dictate the spreading of pathology in the tissue and the cellular impact of the aggregates, thereby contributing to the variety of clinical phenotypes. Here, we present evidence of a novel α-Syn strain induced by the multiple system atrophy-associated oligodendroglial protein p25α. Using an array of biophysical, biochemical, cellular, and in vivo analyses, we demonstrate that compared to α-Syn alone, a substoichiometric concentration of p25α redirects α-Syn aggregation into a unique α-Syn/p25α strain with a different structure and enhanced in vivo prodegenerative properties. The α-Syn/p25α strain induced larger inclusions in human dopaminergic neurons. In vivo, intramuscular injection of preformed fibrils (PFF) of the α-Syn/p25α strain compared to α-Syn PFF resulted in a shortened life span and a distinct anatomical distribution of inclusion pathology in the brain of a human A53T transgenic (line M83) mouse. Investigation of α-Syn aggregates in brain stem extracts of end-stage mice demonstrated that the more aggressive phenotype of the α-Syn/p25α strain was associated with an increased load of α-Syn aggregates based on a Förster resonance energy transfer immunoassay and a reduced α-Syn aggregate seeding activity based on a protein misfolding cyclic amplification assay. When injected unilaterally into the striata of wild-type mice, the α-Syn/p25α strain resulted in a more-pronounced motoric phenotype than α-Syn PFF and exhibited a "tropism" for nigro-striatal neurons compared to α-Syn PFF. Overall, our data support a hypothesis whereby oligodendroglial p25α is responsible for generating a highly prodegenerative α-Syn strain in multiple system atrophy.

Indexed as

alpha-SynucleinAnimalsCell LineHumansInclusion BodiesMiceMice, TransgenicMultiple System AtrophyNerve Tissue ProteinsNeurodegenerative DiseasesOligodendrogliaProtein ConformationProteostasis DeficienciesSubstantia NigraSynucleinopathiesalpha-SynucleinNerve Tissue ProteinsTPPP protein, mouseMultiple system atrophy (MSA)P25αProtein aggregationStrainsTubulin polymerisation-promoting protein (TPPP)Α-Synuclein

Identifiers

PMID33978813
PMCPMC8217051
OpenAlexW3160518917

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.